NO982588L - FremgangsmÕte for diagnose og behandling av plate epitelkarsinom - Google Patents

FremgangsmÕte for diagnose og behandling av plate epitelkarsinom

Info

Publication number
NO982588L
NO982588L NO982588A NO982588A NO982588L NO 982588 L NO982588 L NO 982588L NO 982588 A NO982588 A NO 982588A NO 982588 A NO982588 A NO 982588A NO 982588 L NO982588 L NO 982588L
Authority
NO
Norway
Prior art keywords
diagnosis
procedure
treatment
cell carcinoma
squamous cell
Prior art date
Application number
NO982588A
Other languages
English (en)
Other versions
NO982588D0 (no
NO319903B1 (no
Inventor
Karl-Heinz Heider
G Nter Adolf
Elinborg Ostermann
Erik Patzelt
Marlies Sproll
Original Assignee
Boehringer Ingelheim Int
Karlsruhe Forschzent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19545472A external-priority patent/DE19545472A1/de
Application filed by Boehringer Ingelheim Int, Karlsruhe Forschzent filed Critical Boehringer Ingelheim Int
Publication of NO982588D0 publication Critical patent/NO982588D0/no
Publication of NO982588L publication Critical patent/NO982588L/no
Publication of NO319903B1 publication Critical patent/NO319903B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO19982588A 1995-12-06 1998-06-05 Anvendelse av et antistoffmolekyl for fremstilling av et farmasoytisk preparat for behandling av plateepitelkarsinom. NO319903B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19545472A DE19545472A1 (de) 1995-12-06 1995-12-06 Verfahren zur Diagnose und Therapie von Plattenepithelkarzinomen
DE19615074 1996-04-17
PCT/EP1996/005448 WO1997021104A1 (de) 1995-12-06 1996-12-05 Verfahren zur diagnose und therapie von plattenepithelkarzinomen

Publications (3)

Publication Number Publication Date
NO982588D0 NO982588D0 (no) 1998-06-05
NO982588L true NO982588L (no) 1998-08-05
NO319903B1 NO319903B1 (no) 2005-09-26

Family

ID=26020988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982588A NO319903B1 (no) 1995-12-06 1998-06-05 Anvendelse av et antistoffmolekyl for fremstilling av et farmasoytisk preparat for behandling av plateepitelkarsinom.

Country Status (26)

Country Link
EP (1) EP0865609B1 (no)
JP (1) JP2000502067A (no)
KR (1) KR100473824B1 (no)
CN (1) CN1151377C (no)
AR (1) AR004360A1 (no)
AT (1) ATE235056T1 (no)
AU (1) AU726704B2 (no)
BG (1) BG62985B1 (no)
BR (1) BR9611901A (no)
CA (1) CA2239709A1 (no)
CO (1) CO4520233A1 (no)
CZ (1) CZ174198A3 (no)
DE (1) DE59610248D1 (no)
DK (1) DK0865609T3 (no)
EE (1) EE03783B1 (no)
ES (1) ES2190484T3 (no)
HK (1) HK1011560A1 (no)
MX (1) MX9804459A (no)
NO (1) NO319903B1 (no)
NZ (1) NZ324314A (no)
PL (1) PL184521B1 (no)
PT (1) PT865609E (no)
SK (1) SK284378B6 (no)
TR (1) TR199801027T2 (no)
UY (1) UY24389A1 (no)
WO (1) WO1997021104A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189397B2 (en) * 1999-10-08 2007-03-13 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD44
US20050100542A1 (en) * 1999-10-08 2005-05-12 Young David S. Cytotoxicity mediation of cells evidencing surface expression of CD44
EP1258255A1 (en) * 2001-05-18 2002-11-20 Boehringer Ingelheim International GmbH Conjugates of an antibody to CD44 and a maytansinoid
US6972324B2 (en) 2001-05-18 2005-12-06 Boehringer Ingelheim Pharmaceuticals, Inc. Antibodies specific for CD44v6
BR0210905A (pt) * 2001-05-18 2004-06-08 Boehringer Ingelheim Int Anticorpos especìficos para cd44v6
US20030103985A1 (en) 2001-05-18 2003-06-05 Boehringer Ingelheim International Gmbh Cytotoxic CD44 antibody immunoconjugates
EP1391213A1 (en) * 2002-08-21 2004-02-25 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents
EP1417974A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
MA34010B1 (fr) * 2010-02-04 2013-02-01 Hoffmann La Roche Anticorps monoclonal anti-cd44 destiné à être utilisé pour traiter le carcinome à cellules squameuses de la tête et du cou
US9218450B2 (en) * 2012-11-29 2015-12-22 Roche Molecular Systems, Inc. Accurate and fast mapping of reads to genome
CN112105643B (zh) * 2018-02-22 2023-09-26 普众发现医药科技(上海)有限公司 治疗性抗体及其应用
WO2023227644A2 (en) 2022-05-25 2023-11-30 Akiram Therapeutics Ab Binding protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0703989B1 (en) * 1993-06-18 1997-11-05 Oy Biotie Therapies COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6
JPH08511624A (ja) * 1993-06-22 1996-12-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 腫瘍の診断方法及び分析方法
DE4326573A1 (de) * 1993-08-07 1995-02-23 Boehringer Ingelheim Int Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren
UA58482C2 (uk) * 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти

Also Published As

Publication number Publication date
EE03783B1 (et) 2002-06-17
EP0865609A1 (de) 1998-09-23
AR004360A1 (es) 1998-11-04
EP0865609B1 (de) 2003-03-19
AU726704B2 (en) 2000-11-16
PT865609E (pt) 2003-08-29
NO982588D0 (no) 1998-06-05
PL327066A1 (en) 1998-11-23
NZ324314A (en) 2000-02-28
KR100473824B1 (ko) 2005-09-30
DK0865609T3 (da) 2003-06-23
CA2239709A1 (en) 1997-06-12
DE59610248D1 (de) 2003-04-24
HK1011560A1 (en) 1999-07-16
JP2000502067A (ja) 2000-02-22
CO4520233A1 (es) 1997-10-15
TR199801027T2 (xx) 1998-10-21
MX9804459A (es) 1998-09-30
KR19990071952A (ko) 1999-09-27
BG102513A (en) 1999-02-26
AU1177397A (en) 1997-06-27
NO319903B1 (no) 2005-09-26
ES2190484T3 (es) 2003-08-01
SK73698A3 (en) 1999-01-11
UY24389A1 (es) 2001-10-25
SK284378B6 (sk) 2005-02-04
PL184521B1 (pl) 2002-11-29
CZ174198A3 (cs) 1999-02-17
BG62985B1 (bg) 2000-12-29
WO1997021104A1 (de) 1997-06-12
EE9800164A (et) 1998-12-15
CN1151377C (zh) 2004-05-26
BR9611901A (pt) 1999-03-02
ATE235056T1 (de) 2003-04-15
CN1207811A (zh) 1999-02-10

Similar Documents

Publication Publication Date Title
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
DE69529307D1 (de) Ultraschall-Diagnose- und Behandlungssystem
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO20013002L (no) Blandinger og fremgangsmåter for behandling og diagnose av ovariekreft
KR950703893A (ko) 검사용 첩부제 및 검사방법(diagnostic patch and method for diagnosis using the same)
DE69328363D1 (de) Nichtinvasives testverfahren
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
DE69627513D1 (de) Kochgerät und dessen betriebsverfahren
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
DK1091D0 (da) Immunkonjugater til diagnose og behandling af cancer
DE69522448D1 (de) Gewebebehandlungskassette
NO890793L (no) Fremgangsmaate og installasjon for behandling av vann.
NO991693D0 (no) Forbindelser og metoder for diagnose av tuberkulose
NO903948D0 (no) Fremgangsmaate og anordning for overvaakning av vannandel.
FI971568A (fi) Menetelmä resistenttien kasvainten hoitamiseksi
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
NO982588L (no) FremgangsmÕte for diagnose og behandling av plate epitelkarsinom
NO872064D0 (no) Fremgangsmaate og anordning for perforering av broenn.
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO850642L (no) Fremgangsmaate og anordning ved behandling av vann.
NO895131D0 (no) Fremgangsmaate for analyse av blodplatesammenhopninger og anordning for utfoerelse av fremgangsmaaten.
NZ306122A (en) Rage tumour rejection antigen precursors, diagnosis and treatment thereby
IT1281294B1 (it) Gioiello e procedimento per la realizzazione dello stesso.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.